463 related articles for article (PubMed ID: 7931154)
1. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.
Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154
[TBL] [Abstract][Full Text] [Related]
2. Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro.
Favre D; Petit MA; Trépo C
ALTEX; 2003; 20(3):131-42. PubMed ID: 12947486
[TBL] [Abstract][Full Text] [Related]
3. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
[TBL] [Abstract][Full Text] [Related]
4. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
[TBL] [Abstract][Full Text] [Related]
5. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers.
Treichel U; Meyer zum Büschenfelde KH; Stockert RJ; Poralla T; Gerken G
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3021-9. PubMed ID: 7964611
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.
Delaney WE; Isom HC
Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254
[TBL] [Abstract][Full Text] [Related]
7. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
8. In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus.
Bchini R; Capel F; Dauguet C; Dubanchet S; Petit MA
J Virol; 1990 Jun; 64(6):3025-32. PubMed ID: 2159560
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
10. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
12. High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome.
Dong Q; Liu Z; Chen Y; Chan CY; Lin MC; Kung HF; Chan HL; Sung JJ; He ML
J Virol Methods; 2009 Aug; 159(2):135-40. PubMed ID: 19490966
[TBL] [Abstract][Full Text] [Related]
13. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
[TBL] [Abstract][Full Text] [Related]
14. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
15. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
[TBL] [Abstract][Full Text] [Related]
16. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.
Sun D; Nassal M
J Hepatol; 2006 Nov; 45(5):636-45. PubMed ID: 16935386
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].
Zhang XD; Ren S; Yu HB; Liu YL; Jin Y; Huang YX; Chen JM; Chen XY
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):674-7. PubMed ID: 22152382
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
Murakami Y; Minami M; Daimon Y; Okanoue T
J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
[TBL] [Abstract][Full Text] [Related]
20. Stable expression and integrated hepatitis B virus genome in a human hepatoma cell line.
Wang LY; Li YG; Chen K; Li K; Qu JL; Qin DD; Tang H
Genet Mol Res; 2012 May; 11(2):1442-8. PubMed ID: 22653591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
